You are here

THE BOTTOM LINE

China's vaccine scandal highlights HK's special status

IN MID-JULY, China's state drug administration ordered Changsheng Bio-technology, a company headquartered in Changchun, in northeastern China, to stop production of rabies vaccines after it uncovered evidence of forged data.

At about the same time, the company was fined 3.4 million yuan (...

sentifi.com

Market voices on: